2002 - Prince Mahidol Award
1970 - Robert Koch Prize
P. Helena Mäkelä mostly deals with Immunology, Microbiology, Vaccination, Streptococcus pneumoniae and Meningococcal vaccine. His research in Immunology tackles topics such as Internal medicine which are related to areas like Surgery and Primary care. His biological study spans a wide range of topics, including Bacteria, Virology, Antigen and Escherichia coli.
His Vaccination research is multidisciplinary, incorporating perspectives in Polysaccharide Vaccine and Haemophilus influenzae type. His Pneumococcal infections study in the realm of Streptococcus pneumoniae interacts with subjects such as Carriage. His Meningococcal vaccine study incorporates themes from Incidence and Meningococcal disease.
His scientific interests lie mostly in Microbiology, Immunology, Salmonella, Vaccination and Antibody. The various areas that he examines in his Microbiology study include Virology, Antigen, Escherichia coli, Bacteria and Virulence. His Immunology study combines topics from a wide range of disciplines, such as Haemophilus influenzae, Group A and Streptococcus pneumoniae.
His Vaccination research is multidisciplinary, incorporating elements of Adverse effect, Meningococcal vaccine, Polysaccharide Vaccine, Pediatrics and Conjugate vaccine. In Meningococcal vaccine, P. Helena Mäkelä works on issues like Prevalence, which are connected to Meningitis. His study looks at the intersection of Polysaccharide Vaccine and topics like Polysaccharide with Haemophilus influenzae type.
His main research concerns Streptococcus pneumoniae, Microbiology, Serotype, Immunology and Otitis. His work on Pneumococcal infections as part of general Streptococcus pneumoniae research is frequently linked to Carriage and Good laboratory practice, bridging the gap between disciplines. His Microbiology research incorporates themes from Bacterial outer membrane, Antibody and Medical physics.
P. Helena Mäkelä has researched Bacterial outer membrane in several fields, including Chlamydophila pneumoniae, Viral vector, Antigen and Virology. His Serotype research also works with subjects such as
The scientist’s investigation covers issues in Streptococcus pneumoniae, Microbiology, Pneumococcal infections, Immunology and Otitis. The concepts of his Microbiology study are interwoven with issues in Odds ratio, Bacterial outer membrane and Bacillus subtilis. His Odds ratio study combines topics in areas such as Disease, Multilocus sequence typing, Genotype and Streptococcaceae.
His study in Pneumococcal infections is interdisciplinary in nature, drawing from both Pneumococcal conjugate vaccine, Meningococcal vaccine and Meningococcal disease. His studies deal with areas such as Moraxella catarrhalis, Internal medicine and Myringotomy as well as Immunology. The various areas that P. Helena Mäkelä examines in his Otitis study include Haemophilus influenzae and Moraxella catarrhalis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS: Implications for Vaccine Development and Pathogenesis
Jukka Finne;Maija Leinonen;P.Helena Mäkelä.
The Lancet (1983)
The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type b
Relena Käyhty;Heikki Peltola;Viena Karanko;P. Helena Mäkelä.
The Journal of Infectious Diseases (1983)
Haemophilus influenzae Type b Capsular Polysaccharide Vaccine in Children: A Double-Blind Field Study of 100,000 Vaccinees 3 Months to 5 Years of Age in Finland
Heikki Peltola;Helena Käythy;Aulikki Sivonen;P. Helena Mäkelä.
Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age
Heikki Peltola;P. Helena Mäkelä;Helena Käyhty;Hannele Jousimies.
The New England Journal of Medicine (1977)
Lipopolysaccharide Heterogeneity in Salmonella typhimurium Analyzed by Sodium Dodecyl Sulfate/Polyacrylamide Gel Electrophoresis
E. Tapio Palva;P. Helena Mäkelä.
FEBS Journal (1980)
MANNOSE-RESISTANT HAEMAGGLUTINATION AND P ANTIGEN RECOGNITION ARE CHARACTERISTIC OF ESCHERICHIA COLI CAUSING PRIMARY PYELONEPHRITIS
Vuokko Väisänen;Vuokko Väisänen;LeifG. Tallgren;LeifG. Tallgren;P. Helena Mäkelä;P. Helena Mäkelä;Gunilla Källenius;Gunilla Källenius.
The Lancet (1981)
Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
Terhi Kilpi;Heidi Åhman;Jukka Jokinen;Kari S. Lankinen.
Clinical Infectious Diseases (2003)
Polysaccharide Vaccines of Group A Neisseria meningitidis and Haemophilus influenzae Type b: A Field Trial in Finland
P. Helena Mäkelä;Heikki Peltola;Helena Käyhty;Hannele Jousimies.
The Journal of Infectious Diseases (1977)
Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland.
Camilla Jokinen;Leena Heiskanen;Helvi Juvonen;Sakari Kallinen.
Clinical Infectious Diseases (2001)
Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
Helena Käyhty;Viena Karanko;Heikki Peltola;P. Helena Mäkelä.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: